Canine Gastritis: Diagnosis and Management

Gastritis in dogs is defined as inflammation of the gastric mucosa. This condition presents in acute and chronic forms, each with distinct etiologies, diagnostic approaches, and management strategies. Acute gastritis is often self-limiting and triggered by dietary indiscretion, while chronic gastritis requires systematic investigation to identify underlying causes such as Helicobacter infection, adverse food reactions, or systemic disease. This article provides veterinarians with an evidence-based framework for diagnosing and managing canine gastritis, emphasizing clinical decision-making, diagnostic workup, and treatment protocols supported by peer-reviewed literature.

At a Glance

Pathophysiology and Etiology

Gastritis results from disruption of the gastric mucosal barrier, leading to inflammation, edema, and sometimes erosion or ulceration. The gastric mucosa is protected by mucus secretion, bicarbonate production, epithelial cell turnover, and mucosal blood flow. When these defenses are overwhelmed by irritants, pathogens, or immune-mediated processes, inflammation ensues. Gastritis is a common condition in dogs resulting from inflammation of the gastric mucosa, and the stomach lining can be subjected to irritation by several substances including foreign bodies and food components that may disagree with the canine digestive system (https://doi.org/10.22271/veterinary.2021.v6.i3a.355).

Acute Gastritis Triggers

Dietary indiscretion is the most common cause of acute gastritis in dogs. Ingestion of spoiled food, garbage, foreign bodies, or toxic substances directly irritates the gastric lining. Nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit cyclooxygenase enzymes, reducing prostaglandin synthesis and compromising mucosal protection. Other triggers include infectious agents (viral, bacterial, parasitic), metabolic disturbances, and stress.

Chronic Gastritis Etiologies

Chronic gastritis involves persistent inflammation lasting weeks to months. Recognized causes include:

• Helicobacter spp. infection: These spiral-shaped bacteria colonize the gastric mucosa and can induce chronic inflammation. A case report documented an 8-year-old golden retriever with chronic vomiting and mass-like lesions in the fundus, confirmed as Helicobacter spp. gastritis via histopathology. Treatment with amoxicillin, clarithromycin, and omeprazole resolved clinical signs and ultrasonographic abnormalities (https://doi.org/10.3389/fvets.2022.959526).

• Adverse food reactions: Food allergies or intolerances can trigger lymphocytic-plasmacytic gastritis. Dietary elimination trials are essential for diagnosis.

• Systemic diseases: Gastric ulcer is a significant clinical issue in dogs, with higher prevalence in mature animals and often occurs secondary to systemic diseases such as hepatic or renal disorders, Addison's disease, or shock (https://doi.org/10.51966/jvas.2024.55.3.670-674).

• Atrophic gastritis: A rare condition characterized by destruction of parietal cells and replacement by fibrosis. A case report described a Shih-Tzu dog with chronic vomiting and hematemesis unresponsive to symptomatic treatment. Endoscopy with biopsy confirmed atrophic gastritis, and treatment with corticosteroids and a hypoallergenic diet led to clinical resolution and histologic recovery (https://doi.org/10.5433/1679-0359.2018V39N6P2889).

• Lymphocytic gastritis: An immune-mediated form reported in cats, with potential relevance to dogs. Treatment with cyclosporine has been described (https://doi.org/10.17555/ksvc.2014.04.31.2.108).

• Brachycephalic breeds: Dogs with brachycephalic conformation are predisposed to digestive diseases, including gastritis, due to altered gastrointestinal motility and increased aerophagia (https://pubmed.ncbi.nlm.nih.gov/33187623).

Clinical Presentation and History

Signalment and History

Obtain a thorough history including:

• Onset and duration of vomiting (acute vs. chronic)
• Vomitus characteristics (undigested food, bile, blood, foreign material)
• Frequency and timing of vomiting (postprandial, fasting)
• Dietary history (recent changes, treats, scavenging, access to toxins)
• Medication history (NSAIDs, corticosteroids, antibiotics)
• Travel history and exposure to other animals
• Presence of other clinical signs (diarrhea, weight loss, polyuria, polydipsia)

Physical Examination Findings

Perform a complete physical examination with attention to:

• Hydration status (skin turgor, mucous membrane moisture)
• Abdominal palpation (pain, masses, organomegaly)
• Oral examination (dental disease, ulcers, foreign body)
• Body condition score and muscle condition
• Rectal examination (melena, hematochezia, foreign body)

In acute gastritis, physical examination may be unremarkable except for mild dehydration and cranial abdominal pain. Chronic gastritis may present with weight loss, poor body condition, and signs of systemic disease.

Diagnostic Workup

Minimum Database

For both acute and chronic presentations, initial diagnostics include:

• Complete blood count (CBC): May reveal stress leukogram, anemia (blood loss), or thrombocytopenia
• Serum biochemistry profile: Evaluate renal function, hepatic enzymes, electrolytes, total protein, albumin, and glucose
• Urinalysis: Assess renal concentrating ability and rule out urinary tract infection
• Fecal examination: Direct smear and flotation for parasites (e.g., Physaloptera, Giardia)

A case report of chronic gastritis in an adult Labrador working dog documented elevated blood urea, serum creatinine, and alkaline phosphatase, while other hemato-biochemical parameters remained within normal range (https://doi.org/10.22271/veterinary.2021.v6.i3a.355).

Advanced Diagnostics

Abdominal Imaging

• Survey radiography: Useful for detecting radiopaque foreign bodies, gastric dilation, or mass effects
• Abdominal ultrasonography: Evaluates gastric wall thickness, layering, and presence of masses or foreign bodies. A case of Helicobacter gastritis presented as multiple hypoechoic foci within the gastric lumen on ultrasound (https://doi.org/10.3389/fvets.2022.959526)
• Capsule endoscopy: A non-invasive alternative for patients where anesthesia is contraindicated. A 14-year-old Shih Tzu with acute hemorrhagic vomiting underwent capsule endoscopy due to underlying heart disease, identifying severe gastritis without other GI abnormalities (https://doi.org/10.12729/jbtr.2023.24.3.111)

Endoscopy with Biopsy

Endoscopy is the gold standard for diagnosing chronic gastritis. It allows direct visualization of the gastric mucosa and collection of biopsy samples for histopathology. Indications include:

• Chronic vomiting unresponsive to symptomatic treatment
• Suspected gastric foreign body or mass
• Need for definitive diagnosis of inflammatory or neoplastic conditions

A case of atrophic gastritis in a Shih-Tzu dog was diagnosed only after endoscopic biopsy, which revealed destruction of parietal cells and fibrosis. This diagnosis guided appropriate corticosteroid therapy (https://doi.org/10.5433/1679-0359.2018V39N6P2889).

Histopathologic evaluation should include assessment of:

• Inflammation type (lymphocytic, plasmacytic, eosinophilic, neutrophilic)
• Severity and distribution
• Presence of Helicobacter-like organisms
• Atrophy, fibrosis, or neoplasia

The diagnosis of gastritis and Helicobacter-like organisms infection in endoscopic biopsies requires careful histologic examination (https://pubmed.ncbi.nlm.nih.gov/16573271).

Additional Testing

• Serum cobalamin and folate: Assess for concurrent small intestinal disease
• Canine pancreatic lipase immunoreactivity (cPLI): Rule out pancreatitis
• Adrenocorticotropic hormone (ACTH) stimulation test: Rule out hypoadrenocorticism
• Food elimination trial: Diagnose adverse food reactions

Management of Acute Gastritis

Initial Stabilization

For patients with acute vomiting, address dehydration and electrolyte imbalances:

• Fluid therapy: Intravenous crystalloids (e.g., lactated Ringer's solution) to correct dehydration and maintain perfusion
• Electrolyte monitoring: Potassium supplementation if hypokalemic
• Antiemetics: Maropitant (Cerenia) is the preferred antiemetic for dogs, acting centrally and peripherally. Metoclopramide may be used but is less effective for severe vomiting
• Gastroprotectants: Sucralfate suspension coats ulcerated mucosa. Omeprazole or famotidine reduce gastric acid secretion

Dietary Management

Withhold food for 12-24 hours to allow gastric rest. Then introduce a bland, highly digestible diet:

• Boiled white rice or pasta with lean protein (chicken, turkey, cottage cheese)
• Commercial gastrointestinal prescription diets
• Small, frequent meals (4-6 times daily)

Gradually transition to the regular diet over 3-5 days if vomiting resolves.

Probiotics

The use of probiotics in dogs with acute and chronic gastrointestinal disease has been investigated. A study evaluated SLAB51 probiotics in a veterinary teaching hospital setting (https://doi.org/10.21825/vdt.93194). While evidence supports their role in modulating gut microbiota, specific recommendations require further research.

Management of Chronic Gastritis

Treat Underlying Cause

Successful management depends on identifying and addressing the primary etiology:

• Helicobacter spp. infection: Triple therapy with amoxicillin, clarithromycin, and omeprazole for 21 days has been reported effective (https://doi.org/10.3389/fvets.2022.959526)
• Adverse food reaction: Implement a strict elimination diet using a novel protein or hydrolyzed protein source for 8-12 weeks
• Systemic disease: Treat underlying conditions (e.g., renal disease, hypoadrenocorticism)
• Atrophic gastritis: Corticosteroid therapy (prednisolone) combined with a hypoallergenic, low-fat, high-complex-carbohydrate diet (https://doi.org/10.5433/1679-0359.2018V39N6P2889)
• Lymphocytic gastritis: Immunosuppressive therapy such as cyclosporine may be considered (https://doi.org/10.17555/ksvc.2014.04.31.2.108)

Symptomatic Therapy

• Antiemetics: Maropitant for acute exacerbations
• Gastroprotectants: Omeprazole (proton pump inhibitor) or famotidine (H2 antagonist) for acid suppression
• Mucosal protectants: Sucralfate for erosive or ulcerative gastritis
• Dietary modification: Highly digestible, low-fat, low-fiber diet fed in small, frequent meals

Monitoring and Follow-up

Schedule recheck examinations at 2-4 week intervals to assess clinical response. Repeat endoscopy with biopsy may be indicated to confirm histologic resolution, as demonstrated in the atrophic gastritis case where follow-up endoscopy after 8 months showed normal mucosa (https://doi.org/10.5433/1679-0359.2018V39N6P2889).

Records and Measurements

Maintain detailed medical records including:

• Date of onset and duration of clinical signs
• Vomiting frequency and character (bile, blood, undigested food)
• Dietary history (type, amount, frequency, recent changes)
• Medication history (NSAIDs, antibiotics, supplements)
• Diagnostic test results (CBC, biochemistry, imaging, histopathology)
• Treatment administered (drug, dose, route, frequency, duration)
• Response to therapy (resolution, partial improvement, no change)
• Adverse events or complications

Document serial body weight, body condition score, and muscle condition score at each visit.

Common Failure Patterns

Diagnostic Errors

• Incomplete history: Failure to identify dietary indiscretion, NSAID use, or toxin exposure
• Inadequate diagnostic workup: Relying solely on symptomatic treatment without investigating chronic cases
• Biopsy artifacts: Superficial or inadequate biopsy samples may miss pathology
• Misinterpretation of Helicobacter organisms: Not all Helicobacter-positive dogs have clinically significant gastritis

Treatment Failures

• Non-compliance: Owners not adhering to dietary restrictions or medication schedules
• Incorrect drug selection: Using antiemetics without addressing underlying cause
• Inadequate duration of therapy: Helicobacter treatment requires 21 days of triple therapy
• Failure to identify systemic disease: Chronic kidney disease, hypoadrenocorticism, or hepatic disease may present as gastritis

Recurrence Prevention

• Identify and eliminate triggers (dietary indiscretion, NSAIDs)
• Implement long-term dietary management for food-responsive cases
• Monitor for signs of systemic disease
• Consider probiotic supplementation for gut health

Welfare and Safety Context

Gastritis causes significant discomfort and can progress to life-threatening complications if untreated. Gastric ulceration may lead to perforation, peritonitis, and septic shock. Chronic vomiting results in malnutrition, weight loss, and electrolyte disturbances.

The World Organisation for Animal Health emphasizes the importance of animal health and welfare in veterinary practice (https://www.woah.org/en/what-we-do/animal-health-and-welfare). Veterinarians have a responsibility to provide timely diagnosis and appropriate treatment to alleviate suffering.

Professional Escalation Criteria

Refer to a veterinary internal medicine specialist or emergency facility when:

• Vomiting persists despite 24-48 hours of supportive care
• Hematemesis or melena indicates significant gastrointestinal bleeding
• Patient shows signs of shock (tachycardia, pale mucous membranes, weak pulses)
• Abdominal pain is severe or progressive
• Diagnostic imaging reveals gastric foreign body, mass, or perforation
• Chronic gastritis fails to respond to empirical therapy
• Endoscopy is required for definitive diagnosis

Practical Decision Framework for Differentiating Acute from Chronic Gastritis and Selecting First-Line Therapy

A structured decision framework helps veterinarians move from clinical presentation to targeted management without unnecessary delay or diagnostic omission. The following framework integrates history, physical examination findings, and minimum database results to classify gastritis as acute uncomplicated, acute complicated, or chronic, and to select appropriate first-line therapy. This approach reduces the risk of overlooking underlying systemic disease or progression to gastric ulceration.

Step 1: Triage Based on Duration and Severity

Begin by categorizing the presentation into one of three pathways based on history and physical examination.

Pathway A: Acute Uncomplicated Gastritis

• Vomiting duration less than 48 hours
• No hematemesis or melena
• Normal or mildly dehydrated on physical examination
• No abdominal pain on palpation
• No systemic signs (fever, lethargy, anorexia beyond 24 hours)
• Known or suspected dietary indiscretion

Pathway B: Acute Complicated Gastritis

• Vomiting duration 48 to 72 hours
• Hematemesis (fresh blood or coffee-ground vomitus) or melena present
• Moderate to severe dehydration
• Cranial abdominal pain on palpation
• Tachycardia or pale mucous membranes
• Known NSAID administration or toxin exposure

Pathway C: Chronic Gastritis

• Vomiting duration greater than 2 weeks
• Intermittent or persistent vomiting
• Weight loss or poor body condition
• Concurrent diarrhea or other gastrointestinal signs
• Poor response to empirical symptomatic therapy
• Brachycephalic breed conformation

Apply this triage at the first consultation. Document the pathway assignment in the medical record along with the date and time of assessment.

Step 2: Minimum Database Interpretation for Pathway Assignment

For all pathways, collect a minimum database including packed cell volume (PCV), total solids (TS), blood glucose, blood urea nitrogen (BUN), and electrolytes if available. For Pathway B and C, add a complete blood count and serum biochemistry profile.

Interpretation thresholds for decision-making:

A case report of chronic gastritis in an adult Labrador working dog documented elevated blood urea, serum creatinine, and alkaline phosphatase while other parameters remained normal (https://doi.org/10.22271/veterinary.2021.v6.i3a.355). This pattern should prompt investigation for renal disease as a contributing factor.

Step 3: First-Line Therapy Selection by Pathway

Pathway A: Acute Uncomplicated Gastritis

• Withhold food for 12 to 24 hours
• Provide fresh water ad libitum or offer small amounts of water frequently
• Administer maropitant 1 mg/kg subcutaneously once daily for up to 5 days if vomiting persists beyond 12 hours
• No routine gastroprotectants unless NSAID history is identified
• After 24 hours, introduce a bland diet: boiled white rice or pasta with lean boiled chicken or cottage cheese, fed in 4 to 6 small meals per day
• Transition to regular diet over 3 to 5 days if vomiting resolves
• No antibiotics indicated

Pathway B: Acute Complicated Gastritis

• Hospitalize for intravenous fluid therapy with lactated Ringer's solution or Normosol-R
• Correct dehydration over 4 to 6 hours, then maintain at 60 mL/kg/day
• Administer maropitant 1 mg/kg subcutaneously once daily
• Add omeprazole 1 mg/kg orally every 12 hours for acid suppression
• Add sucralfate 0.5 to 1 gram orally every 8 hours, given 2 hours apart from other medications
• If hematemesis is severe or PCV is dropping, consider blood transfusion
• Perform abdominal ultrasound to evaluate for gastric ulcer, foreign body, or mass
• If NSAID-induced, discontinue NSAID and consider misoprostol 2 to 5 mcg/kg orally every 8 hours
• Monitor PCV, TS, and electrolytes every 12 to 24 hours
• If no improvement in 48 hours, refer for endoscopy

Pathway C: Chronic Gastritis

• Do not rely on symptomatic therapy alone
• Perform abdominal ultrasound to assess gastric wall thickness, layering, and presence of masses or foreign bodies
• Collect serum for cobalamin and folate, canine pancreatic lipase immunoreactivity, and ACTH stimulation test if hypoadrenocorticism is suspected
• Initiate a strict elimination diet using a novel protein or hydrolyzed protein source for 8 to 12 weeks
• Administer maropitant as needed for vomiting episodes, but avoid long-term daily use
• Consider omeprazole 1 mg/kg orally every 12 hours if erosive gastritis is suspected
• Schedule endoscopy with biopsy if no improvement after 2 weeks of dietary modification
• If Helicobacter infection is confirmed on histopathology, treat with amoxicillin 20 mg/kg orally every 12 hours, clarithromycin 10 mg/kg orally every 12 hours, and omeprazole 1 mg/kg orally every 12 hours for 21 days (https://doi.org/10.3389/fvets.2022.959526)

Step 4: Reassessment and Escalation Criteria

Reassess the patient at defined intervals and escalate care if criteria are met.

Reassessment at 24 hours (Pathway A and B):

• Is vomiting frequency reduced by at least 50%?
• Is the patient able to tolerate small amounts of water?
• Are hydration status and electrolytes improving?

If no improvement, move to Pathway B or refer for endoscopy.

Reassessment at 48 hours (Pathway B):

• Has hematemesis resolved?
• Is PCV stable or improving?
• Is abdominal pain reduced?

If hematemesis persists, PCV continues to drop, or abdominal pain worsens, refer immediately for emergency endoscopy or surgery.

Reassessment at 2 weeks (Pathway C):

• Has vomiting frequency decreased?
• Is the patient maintaining or gaining weight?
• Is the elimination diet being strictly followed?

If no improvement, proceed to endoscopy with biopsy. A case of atrophic gastritis in a Shih-Tzu dog was diagnosed only after endoscopic biopsy, which revealed destruction of parietal cells and fibrosis, guiding appropriate corticosteroid therapy (https://doi.org/10.5433/1679-0359.2018V39N6P2889).

Step 5: Documentation and Record Keeping

Maintain a structured record for each gastritis case using the following template:

Gastritis Case Record

Document serial body weight, body condition score, and muscle condition score at each reassessment.

Common Failure Patterns in Decision-Making

Failure Pattern 1: Treating chronic gastritis as acute Veterinarians may repeatedly prescribe antiemetics and dietary rest for dogs with chronic vomiting without performing a diagnostic workup. This delays identification of underlying causes such as Helicobacter infection, adverse food reactions, or systemic disease. A case report documented an 8-year-old golden retriever with chronic vomiting and mass-like lesions in the fundus, confirmed as Helicobacter spp. gastritis via histopathology. Treatment with amoxicillin, clarithromycin, and omeprazole resolved clinical signs and ultrasonographic abnormalities (https://doi.org/10.3389/fvets.2022.959526). Without endoscopy, this diagnosis would have been missed.

Failure Pattern 2: Overlooking NSAID history Owners may not volunteer NSAID administration, especially if they consider over-the-counter products harmless. Always ask specifically about human NSAIDs (ibuprofen, naproxen, aspirin) and veterinary NSAIDs (carprofen, meloxicam, deracoxib). Gastric ulcer is a significant clinical issue in dogs, with higher prevalence in mature animals and often occurs secondary to systemic diseases such as hepatic or renal disorders, Addison's disease, or shock (https://doi.org/10.51966/jvas.2024.55.3.670-674). NSAID-induced gastritis requires immediate discontinuation of the drug and aggressive gastroprotection.

Failure Pattern 3: Inadequate duration of Helicobacter therapy Triple therapy for Helicobacter must be administered for a full 21 days. Shorter courses lead to treatment failure and antimicrobial resistance. The case report documenting successful treatment used amoxicillin 400 mg and clarithromycin 180 mg twice daily for 21 days with omeprazole 20 mg once daily for 34 days (https://doi.org/10.3389/fvets.2022.959526). Document the start and end dates of therapy in the medical record.

Failure Pattern 4: Ignoring brachycephalic breed predisposition Dogs with brachycephalic conformation are predisposed to digestive diseases, including gastritis, due to altered gastrointestinal motility and increased aerophagia (https://pubmed.ncbi.nlm.nih.gov/33187623). In these patients, chronic gastritis may be multifactorial and require management of upper airway obstruction in addition to dietary and medical therapy.

Failure Pattern 5: Relying on capsule endoscopy without biopsy Capsule endoscopy is a non-invasive alternative for patients where anesthesia is contraindicated. A case report documented its use in a 14-year-old Shih Tzu with acute hemorrhagic vomiting and underlying heart disease, identifying severe gastritis without other GI abnormalities (https://doi.org/10.12729/jbtr.2023.24.3.111). However, capsule endoscopy does not allow biopsy collection. For chronic gastritis, histopathology is essential for definitive diagnosis. Do not substitute capsule endoscopy for traditional endoscopy when biopsy is indicated.

Welfare and Safety Context for Decision-Making

The World Organisation for Animal Health emphasizes the importance of animal health and welfare in veterinary practice (https://www.woah.org/en/what-we-do/animal-health-and-welfare). Delayed diagnosis of chronic gastritis leads to prolonged discomfort, malnutrition, and progression to gastric ulceration or perforation. The decision framework above is designed to minimize diagnostic delay while avoiding unnecessary invasive procedures in self-limiting cases.

Gastritis causes significant discomfort and can progress to life-threatening complications if untreated. Gastric ulceration may lead to perforation, peritonitis, and septic shock. Chronic vomiting results in malnutrition, weight loss, and electrolyte disturbances. Veterinarians have a responsibility to provide timely diagnosis and appropriate treatment to alleviate suffering.

Professional Escalation Criteria

Refer to a veterinary internal medicine specialist or emergency facility when:

• Vomiting persists despite 48 hours of appropriate therapy in Pathway B
• Hematemesis or melena continues after 48 hours of gastroprotectant therapy
• PCV drops below 25% or patient requires blood transfusion
• Abdominal ultrasound reveals gastric mass, foreign body, or evidence of perforation
• Endoscopy is required for definitive diagnosis and biopsy
• Chronic gastritis fails to respond to 2 weeks of dietary modification and symptomatic therapy
• Patient shows signs of shock (tachycardia, pale mucous membranes, weak pulses, prolonged capillary refill time)
• Severe abdominal pain is present and progressive

Integration with Existing Diagnostic and Management Sections

This decision framework complements the diagnostic workup and management sections by providing a structured approach to initial patient classification and first-line therapy selection. It does not replace the need for endoscopy with biopsy in chronic cases, nor does it substitute for thorough history-taking and physical examination. Instead, it provides a reproducible method for moving from presentation to action while maintaining diagnostic rigor.

Use this framework in conjunction with the minimum database interpretation guidelines, imaging recommendations, and treatment protocols detailed in the diagnostic workup and management sections. Document each step in the medical record to facilitate continuity of care and outcome assessment.

Practical Decision Framework for Differentiating Acute from Chronic Gastritis and Selecting First-Line Therapy

A structured decision framework helps veterinarians move from clinical presentation to targeted management without unnecessary delay or diagnostic omission. The following framework integrates history, physical examination findings, and minimum database results to classify gastritis as acute uncomplicated, acute complicated, or chronic, and to select appropriate first-line therapy. This approach reduces the risk of overlooking underlying systemic disease or progression to gastric ulceration.

Step 1: Triage Based on Duration and Severity

Begin by categorizing the presentation into one of three pathways based on history and physical examination.

Pathway A: Acute Uncomplicated Gastritis

• Vomiting duration less than 48 hours
• No hematemesis or melena
• Normal or mildly dehydrated on physical examination
• No abdominal pain on palpation
• No systemic signs (fever, lethargy, anorexia beyond 24 hours)
• Known or suspected dietary indiscretion

Pathway B: Acute Complicated Gastritis

• Vomiting duration 48 to 72 hours
• Hematemesis (fresh blood or coffee-ground vomitus) or melena present
• Moderate to severe dehydration
• Cranial abdominal pain on palpation
• Tachycardia or pale mucous membranes
• Known NSAID administration or toxin exposure

Pathway C: Chronic Gastritis

• Vomiting duration greater than 2 weeks
• Intermittent or persistent vomiting
• Weight loss or poor body condition
• Concurrent diarrhea or other gastrointestinal signs
• Poor response to empirical symptomatic therapy
• Brachycephalic breed conformation

Apply this triage at the first consultation. Document the pathway assignment in the medical record along with the date and time of assessment.

Step 2: Minimum Database Interpretation for Pathway Assignment

For all pathways, collect a minimum database including packed cell volume (PCV), total solids (TS), blood glucose, blood urea nitrogen (BUN), and electrolytes if available. For Pathway B and C, add a complete blood count and serum biochemistry profile.

Interpretation thresholds for decision-making:

A case report of chronic gastritis in an adult Labrador working dog documented elevated blood urea, serum creatinine, and alkaline phosphatase while other parameters remained normal (https://doi.org/10.22271/veterinary.2021.v6.i3a.355). This pattern should prompt investigation for renal disease as a contributing factor.

Step 3: First-Line Therapy Selection by Pathway

Pathway A: Acute Uncomplicated Gastritis

• Withhold food for 12 to 24 hours
• Provide fresh water ad libitum or offer small amounts of water frequently
• Administer maropitant 1 mg/kg subcutaneously once daily for up to 5 days if vomiting persists beyond 12 hours
• No routine gastroprotectants unless NSAID history is identified
• After 24 hours, introduce a bland diet: boiled white rice or pasta with lean boiled chicken or cottage cheese, fed in 4 to 6 small meals per day
• Transition to regular diet over 3 to 5 days if vomiting resolves
• No antibiotics indicated

Pathway B: Acute Complicated Gastritis

• Hospitalize for intravenous fluid therapy with lactated Ringer's solution or Normosol-R
• Correct dehydration over 4 to 6 hours, then maintain at 60 mL/kg/day
• Administer maropitant 1 mg/kg subcutaneously once daily
• Add omeprazole 1 mg/kg orally every 12 hours for acid suppression
• Add sucralfate 0.5 to 1 gram orally every 8 hours, given 2 hours apart from other medications
• If hematemesis is severe or PCV is dropping, consider blood transfusion
• Perform abdominal ultrasound to evaluate for gastric ulcer, foreign body, or mass
• If NSAID-induced, discontinue NSAID and consider misoprostol 2 to 5 mcg/kg orally every 8 hours
• Monitor PCV, TS, and electrolytes every 12 to 24 hours
• If no improvement in 48 hours, refer for endoscopy

Pathway C: Chronic Gastritis

• Do not rely on symptomatic therapy alone
• Perform abdominal ultrasound to assess gastric wall thickness, layering, and presence of masses or foreign bodies
• Collect serum for cobalamin and folate, canine pancreatic lipase immunoreactivity, and ACTH stimulation test if hypoadrenocorticism is suspected
• Initiate a strict elimination diet using a novel protein or hydrolyzed protein source for 8 to 12 weeks
• Administer maropitant as needed for vomiting episodes, but avoid long-term daily use
• Consider omeprazole 1 mg/kg orally every 12 hours if erosive gastritis is suspected
• Schedule endoscopy with biopsy if no improvement after 2 weeks of dietary modification
• If Helicobacter infection is confirmed on histopathology, treat with amoxicillin 20 mg/kg orally every 12 hours, clarithromycin 10 mg/kg orally every 12 hours, and omeprazole 1 mg/kg orally every 12 hours for 21 days (https://doi.org/10.3389/fvets.2022.959526)

Step 4: Reassessment and Escalation Criteria

Reassess the patient at defined intervals and escalate care if criteria are met.

Reassessment at 24 hours (Pathway A and B):

• Is vomiting frequency reduced by at least 50%?
• Is the patient able to tolerate small amounts of water?
• Are hydration status and electrolytes improving?

If no improvement, move to Pathway B or refer for endoscopy.

Reassessment at 48 hours (Pathway B):

• Has hematemesis resolved?
• Is PCV stable or improving?
• Is abdominal pain reduced?

If hematemesis persists, PCV continues to drop, or abdominal pain worsens, refer immediately for emergency endoscopy or surgery.

Reassessment at 2 weeks (Pathway C):

• Has vomiting frequency decreased?
• Is the patient maintaining or gaining weight?
• Is the elimination diet being strictly followed?

If no improvement, proceed to endoscopy with biopsy. A case of atrophic gastritis in a Shih-Tzu dog was diagnosed only after endoscopic biopsy, which revealed destruction of parietal cells and fibrosis, guiding appropriate corticosteroid therapy (https://doi.org/10.5433/1679-0359.2018V39N6P2889).

Step 5: Documentation and Record Keeping

Maintain a structured record for each gastritis case using the following template:

Gastritis Case Record

Document serial body weight, body condition score, and muscle condition score at each reassessment.

Common Failure Patterns in Decision-Making

Failure Pattern 1: Treating chronic gastritis as acute Veterinarians may repeatedly prescribe antiemetics and dietary rest for dogs with chronic vomiting without performing a diagnostic workup. This delays identification of underlying causes such as Helicobacter infection, adverse food reactions, or systemic disease. A case report documented an 8-year-old golden retriever with chronic vomiting and mass-like lesions in the fundus, confirmed as Helicobacter spp. gastritis via histopathology. Treatment with amoxicillin, clarithromycin, and omeprazole resolved clinical signs and ultrasonographic abnormalities (https://doi.org/10.3389/fvets.2022.959526). Without endoscopy, this diagnosis would have been missed.

Failure Pattern 2: Overlooking NSAID history Owners may not volunteer NSAID administration, especially if they consider over-the-counter products harmless. Always ask specifically about human NSAIDs (ibuprofen, naproxen, aspirin) and veterinary NSAIDs (carprofen, meloxicam, deracoxib). Gastric ulcer is a significant clinical issue in dogs, with higher prevalence in mature animals and often occurs secondary to systemic diseases such as hepatic or renal disorders, Addison's disease, or shock (https://doi.org/10.51966/jvas.2024.55.3.670-674). NSAID-induced gastritis requires immediate discontinuation of the drug and aggressive gastroprotection.

Failure Pattern 3: Inadequate duration of Helicobacter therapy Triple therapy for Helicobacter must be administered for a full 21 days. Shorter courses lead to treatment failure and antimicrobial resistance. The case report documenting successful treatment used amoxicillin 400 mg and clarithromycin 180 mg twice daily for 21 days with omeprazole 20 mg once daily for 34 days (https://doi.org/10.3389/fvets.2022.959526). Document the start and end dates of therapy in the medical record.

Failure Pattern 4: Ignoring brachycephalic breed predisposition Dogs with brachycephalic conformation are predisposed to digestive diseases, including gastritis, due to altered gastrointestinal motility and increased aerophagia (https://pubmed.ncbi.nlm.nih.gov/33187623). In these patients, chronic gastritis may be multifactorial and require management of upper airway obstruction in addition to dietary and medical therapy.

Failure Pattern 5: Relying on capsule endoscopy without biopsy Capsule endoscopy is a non-invasive alternative for patients where anesthesia is contraindicated. A case report documented its use in a 14-year-old Shih Tzu with acute hemorrhagic vomiting and underlying heart disease, identifying severe gastritis without other GI abnormalities (https://doi.org/10.12729/jbtr.2023.24.3.111). However, capsule endoscopy does not allow biopsy collection. For chronic gastritis, histopathology is essential for definitive diagnosis. Do not substitute capsule endoscopy for traditional endoscopy when biopsy is indicated.

Welfare and Safety Context for Decision-Making

The World Organisation for Animal Health emphasizes the importance of animal health and welfare in veterinary practice (https://www.woah.org/en/what-we-do/animal-health-and-welfare). Delayed diagnosis of chronic gastritis leads to prolonged discomfort, malnutrition, and progression to gastric ulceration or perforation. The decision framework above is designed to minimize diagnostic delay while avoiding unnecessary invasive procedures in self-limiting cases.

Gastritis causes significant discomfort and can progress to life-threatening complications if untreated. Gastric ulceration may lead to perforation, peritonitis, and septic shock. Chronic vomiting results in malnutrition, weight loss, and electrolyte disturbances. Veterinarians have a responsibility to provide timely diagnosis and appropriate treatment to alleviate suffering.

Professional Escalation Criteria

Refer to a veterinary internal medicine specialist or emergency facility when:

• Vomiting persists despite 48 hours of appropriate therapy in Pathway B
• Hematemesis or melena continues after 48 hours of gastroprotectant therapy
• PCV drops below 25% or patient requires blood transfusion
• Abdominal ultrasound reveals gastric mass, foreign body, or evidence of perforation
• Endoscopy is required for definitive diagnosis and biopsy
• Chronic gastritis fails to respond to 2 weeks of dietary modification and symptomatic therapy
• Patient shows signs of shock (tachycardia, pale mucous membranes, weak pulses, prolonged capillary refill time)
• Severe abdominal pain is present and progressive

Integration with Existing Diagnostic and Management Sections

This decision framework complements the diagnostic workup and management sections by providing a structured approach to initial patient classification and first-line therapy selection. It does not replace the need for endoscopy with biopsy in chronic cases, nor does it substitute for thorough history-taking and physical examination. Instead, it provides a reproducible method for moving from presentation to action while maintaining diagnostic rigor.

Use this framework in conjunction with the minimum database interpretation guidelines, imaging recommendations, and treatment protocols detailed in the diagnostic workup and management sections. Document each step in the medical record to facilitate continuity of care and outcome assessment.

Frequently Asked Questions

What are the most common causes of acute gastritis in dogs?

Dietary indiscretion is the most frequent cause, including ingestion of spoiled food, garbage, foreign bodies, or toxic substances. NSAID administration is another common trigger. Viral or bacterial infections, metabolic disturbances, and stress can also cause acute gastritis.

How is chronic gastritis diagnosed definitively?

Endoscopy with gastric biopsy and histopathologic examination is the gold standard for diagnosing chronic gastritis. This allows visualization of the mucosa and collection of tissue samples to identify inflammation type, severity, and underlying causes such as Helicobacter infection or atrophic changes.

Can Helicobacter infection cause gastritis in dogs?

Yes, Helicobacter spp. infection can cause chronic gastritis in dogs. A case report documented an 8-year-old golden retriever with chronic vomiting and mass-like gastric lesions confirmed as Helicobacter gastritis. Treatment with amoxicillin, clarithromycin, and omeprazole resolved clinical signs (https://doi.org/10.3389/fvets.2022.959526).

What dietary changes help manage chronic gastritis?

A highly digestible, low-fat, low-fiber diet is recommended. For food-responsive cases, a novel protein or hydrolyzed protein elimination diet should be implemented for 8-12 weeks. Small, frequent meals reduce gastric distension and vomiting episodes.

When should I refer a dog with gastritis to a specialist?

Referral to a veterinary internal medicine specialist is indicated when vomiting persists despite 24-48 hours of supportive care, hematemesis or melena is present, diagnostic imaging reveals abnormalities requiring endoscopy, or chronic gastritis fails to respond to empirical therapy.

Is capsule endoscopy a reliable alternative to traditional endoscopy?

Capsule endoscopy is a non-invasive alternative for patients where anesthesia is contraindicated. A case report documented its use in a dog with acute hemorrhagic vomiting and underlying heart disease, identifying severe gastritis without other GI abnormalities (https://doi.org/10.12729/jbtr.2023.24.3.111). However, it does not allow biopsy collection.

What is atrophic gastritis and how is it treated?

Atrophic gastritis is a rare condition characterized by destruction of parietal cells and replacement by fibrosis. Treatment involves corticosteroids for anti-inflammatory effects and parietal cell regeneration, combined with a soft, hypoallergenic, low-fat, high-complex-carbohydrate diet. Follow-up endoscopy after 8 months may show mucosal recovery (https://doi.org/10.5433/1679-0359.2018V39N6P2889).

Can probiotics help dogs with gastritis?

Probiotics may support gut health in dogs with acute and chronic gastrointestinal disease. A study evaluated SLAB51 probiotics in a veterinary teaching hospital setting (https://doi.org/10.21825/vdt.93194). While evidence supports their role in modulating gut microbiota, specific recommendations require further research and should be tailored to individual cases.

Related Veterinary Guides

• Dog
• Dog Shedding Management
• How To Skin A Dog
• Arthritis In Dogs Symptoms And Diagnosis
• Canine Hyperadrenocorticism Cushings Diagnostic Management

References and Further Reading

• www.merckvetmanual.com
• www.aaha.org
• www.acvim.org
• Merck Veterinary Manual. Merck Veterinary Manual.
• Animal Health and Welfare. World Organisation for Animal Health.
• Canine gastritis.. The Veterinary clinics of North America. Small animal practice, 2003.
• Canine Gastric Pathology: A Review.. Journal of comparative pathology, 2016.
• Digestive Diseases in Brachycephalic Dogs.. The Veterinary clinics of North America. Small animal practice, 2021.
• The diagnosis of gastritis and helicobacter-like organisms infection in endoscopic biopsies of the canine gastric mucosa.. Polish journal of veterinary sciences, 2006.
• Gastric helicobacters in cats.. Journal of feline medicine and surgery, 2000.
• [Gastritis].. Naika. Internal medicine, 1966.
• Treatment of chronic gastritis in an adult labrador working dog: A case study. International Journal of Veterinary Sciences and Animal Husbandry, 2021.
• Comprehensive evaluation and management of chronic gastritis in a dog: A case report. Journal of Veterinary and Animal Sciences, 2024.
• Ultrasonographic and endoscopic guidance in diagnosis of Helicobacter gastritis presenting as a mass lesion in a dog: A case report. Frontiers in Veterinary Science, 2022.
• Atrophic gastritis in a Shih-Tzu dog - case report. 2018.
• Clinical application of capsule endoscopy in a dog with acute hemorrhagic vomiting. Journal of Biomedicine and Translational Research, 2023.
• Treatment of lymphocytic gastritis with cyclosporine in a cat. Journal of Veterinary Clinics, 2014.
• The use of SLAB51TM probiotics in dogs with acute and chronic gastrointestinal disease in a veterinary teaching hospital. Vlaams Diergeneeskundig Tijdschrift, 2024.
• Chronic kidney disease in a dog with hematologic and cardiovascular alterations: A case report. Open Veterinary Journal, 2026.
• First description of semiquantitative strain elastography in a dog with chronic inflammatory enteropathy. Revista Brasileira De Medicina Veterinaria, 2025.

This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.